A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

    April 2021 in “ Clinical, Cosmetic and Investigational Dermatology ”
    Shuying Lv, Lei Wang, Xiaohui Zou, Zihan Wang, Baoquan Qu, Wen Wei Lin, Dingquan Yang
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Selenium sulfide →
    Image
    Studysummary This report describes a case of acute telogen effluvium in a 38-year-old woman following recovery from COVID-19.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Three years ago, a case study was reported of a 38-year-old woman who experienced acute telogen effluvium (ATE), a condition characterized by sudden and temporary hair loss, after recovering from COVID-19. The patient presented with severe hair loss (>150 hairs/day), oily scalp, and trichodynia (scalp pain). After 3 months of treatment with topical 5% minoxidil and selenium sulfide lotion, her hair loss significantly alleviated and new hairs grew out. The study suggested that SARS-CoV-2 infection could be a trigger for ATE. Other studies cited in the report found a high prevalence of alopecia (48.5%) among COVID-19 survivors in Wuhan, China, and a significant increase in ATE cases during the pandemic. However, the exact mechanism linking COVID-19 and telogen effluvium remained unclear.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results